Copyright
©The Author(s) 2025.
World J Gastroenterol. Feb 14, 2025; 31(6): 102070
Published online Feb 14, 2025. doi: 10.3748/wjg.v31.i6.102070
Published online Feb 14, 2025. doi: 10.3748/wjg.v31.i6.102070
Figure 2 Effect of different concentrations of keratin 1 antibody on the expression levels of high molecular weight kininogen and bradykinin in Caco-2 cells.
A: Immunofluorescence analysis shows a reduction in high molecular weight kininogen expression in Caco-2 cells treated with different concentrations of keratin 1 (KRT1) antibody; B: Enzyme-linked immunosorbent assay results demonstrate an increase in bradykinin expression in Caco-2 cells treated with various concentrations of KRT1 antibody. aP < 0.05. cP < 0.001. P value vs control group. Treatment 1: Keratin 1 (KRT1) antibody at 1 ng/mL; Treatment 2: KRT1 antibody at 5 ng/mL; Treatment 3: KRT1 antibody at 10 ng/mL. ELISA: Enzyme-linked immunosorbent assay.
- Citation: Dong XQ, Zhang YH, Luo J, Li MJ, Ma LQ, Qi YT, Miao YL. Keratin 1 modulates intestinal barrier and immune response via kallikrein kinin system in ulcerative colitis. World J Gastroenterol 2025; 31(6): 102070
- URL: https://www.wjgnet.com/1007-9327/full/v31/i6/102070.htm
- DOI: https://dx.doi.org/10.3748/wjg.v31.i6.102070